Antigenics Oncophage Retrospective Testing For Potency Is Approval Issue

Approval of Antigenics’ Phase III cancer vaccine Oncophage rests on whether FDA will accept retrospective testing of vaccine used in pivotal trials to support product characterization, the company said.

More from Archive

More from Pink Sheet